Related references
Note: Only part of the references are listed.Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study
Tessa Straatmijer et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)
Breaking the therapeutic ceiling in drug development in ulcerative colitis
Dahham Alsoud et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Monitoring vedolizumab and ustekinumab drug levels in patients with inflammatory bowel disease: hype or hope?
Dahham Alsoud et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response
Mark A. Samaan et al.
FRONTLINE GASTROENTEROLOGY (2020)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Variable selection for propensity score models
M. Alan Brookhart et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)